Replies to post #71388 on Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

I disagree with the notion that we have nothing to show for it. In three years we have secured:

1) a $475 million partnership
2) submission for approval
3) two techs on the bleeding edge of immunotherapy


These are not small beans. Could things have moved faster? Yes. But I'm just reinforcing the point that management has not been a complete failure, and that we are now sitting on a nice trove of actionable programs, no matter what the market cap reflects.